Alliance Pharma plc (LON:APH) is scheduled to be announcing its earnings results before the market opens on Wednesday, September 13th.

Shares of Alliance Pharma plc (APH) opened at 51.88 on Monday. The firm’s market cap is GBX 245.22 million. The firm’s 50-day moving average price is GBX 52.79 and its 200 day moving average price is GBX 50.49. Alliance Pharma plc has a 52 week low of GBX 41.33 and a 52 week high of GBX 57.50.

COPYRIGHT VIOLATION WARNING: “Alliance Pharma plc (APH) to Release Quarterly Earnings on Wednesday” was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this news story on another domain, it was illegally copied and republished in violation of United States and international trademark & copyright law. The correct version of this news story can be read at https://www.thecerbatgem.com/2017/09/11/alliance-pharma-plc-aph-to-release-quarterly-earnings-on-wednesday.html.

A number of equities research analysts recently weighed in on the company. FinnCap reissued a “buy” rating and set a GBX 65 ($0.84) target price on shares of Alliance Pharma plc in a research report on Tuesday, May 30th. Numis Securities Ltd reissued a “buy” rating and set a GBX 60 ($0.77) target price on shares of Alliance Pharma plc in a research report on Tuesday, July 18th.

Alliance Pharma plc Company Profile

Alliance Pharma plc is a United Kingdom-based specialty pharmaceutical company. The Company is engaged in acquisition, marketing and distribution of pharmaceutical products. The Company operates in various business areas, such as Hydromol, secondary care, community and consumer products, established products and international.

Receive News & Stock Ratings for Alliance Pharma plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alliance Pharma plc and related stocks with our FREE daily email newsletter.